In routine cirrhosis practice, what are the main practical barriers to embedding evidence-based alcohol use disorder treatment within hepatology care?

The biggest barrier to providing care can be seen when we define the scope of practice and the training of hepatologists.

Just like how some of us prescribe GLP1a to F2-F3 patients with MASH or provide lifestyle counseling to people with MASLD, but ultimately we do not provide as comprehensive care a...